PB Fintech

POLICYBZR is in a strong downtrend across daily, weekly, and monthly horizons, with the price trading below all key moving averages and the Supertrend indicator. As of 2026-11-06, the stock closed at ₹967.00, reflecting a -45.0% return over the past year and a current drawdown of -56.4%. The daily ADX of 48.08 indicates strong trend conviction, while the Minus DI (33.59) significantly outweighs the Plus DI (11.78), confirming bearish momentum. Price positioning is near the lower end of its 252-day range (+4.9%) and 50-day range (+5.2%). A Doji pattern formed on 2026-11-06 suggests indecision after recent volatility, including a moderate upward gap on 2026-11-05. Immediate resistance sits at ₹969.67 (pivot, +0.28%), while support is found at ₹960.33 (-0.69%). Annualized volatility stands at +47.5%, highlighting significant risk.

In the seven-day window ending November 6, 2026, Policybazaar (PB Fintech) experienced significant price volatility following its Q2 earnings release. On November 2, shares fell 7% to hit a 52-week low as the market reacted to mixed financial results. While total insurance premiums surged 38% year-on-year, adjusted EBITDA missed expectations due to higher advertising expenses, and sequential momentum in credit disbursals was muted as the company curbed marketing growth to manage costs and regulatory risks.

Despite the immediate negative price reaction, Jefferies issued a 'Buy' call on November 2 with a target price of ₹1,540, citing that revenue growth outpaced expectations despite the EBITDA miss. This divergence highlights a split in analyst sentiment between short-term profitability pressures and longer-term revenue trajectory. Broader market context saw Indian benchmarks rally on November 2, reclaiming the Nifty 23,400 mark driven by strong corporate earnings from peers like Reliance Industries and Dixon Technologies, though this macro tailwind did not prevent PB Fintech’s specific decline.

PB Fintech Limited (Policybazaar) reported unaudited financial results for the quarter and half-year ended September 30, 2026. The company posted consolidated operating revenue of ₹2,178 Cr and a profit after tax (PAT) of ₹192 Cr for Q2 FY 2026-27. Total insurance premium facilitated during the quarter stood at ₹9,385 Cr. Management addressed potential impacts from the Insurance Regulatory and Development Authority of India’s (IRDAI) consultation paper on distribution payouts, noting that while the final regulatory framework has not yet been issued, the company intends to implement it once finalized. These disclosures were filed with the NSE following Board approval on October 30, 2026.

PB Fintech (PolicyBazaar) demonstrates a strengthening operating trajectory in Q2 FY2026-27, with revenue from operations rising sequentially to ₹2,178 crore and net profit increasing to ₹192 crore. This follows a robust annual trend where sales grew to ₹6,794 crore in FY2026, up from ₹4,977 crore in FY2025, while operating profit surged from ₹93 crore to ₹508 crore. Earnings quality has improved significantly, evidenced by the Cash Flow from Operations/EBITDA ratio turning positive at 15% in FY2026, compared to negative values in prior years. Return on Capital Employed (ROCE) also climbed to 10% in FY2026, up from 6% in FY2025.

However, balance-sheet health shows mixed signals. While cash reserves grew to ₹390 crore as of September 2026, trade receivables more than doubled to ₹2,116 crore, contributing to an extended Cash Conversion Cycle of 93 days. Borrowings have also risen steadily, reaching ₹410 crore in September 2026. Institutional ownership is shifting, with DIIs increasing their stake to 44.85% while FIIs reduced theirs to 27.12%. The key checkpoint remains monitoring whether the rapid growth in receivables impacts working capital efficiency and cash flow generation in subsequent quarters.

PB Fintech faces significant near-term headwinds, evidenced by a 7% share price drop to a 52-week low following its Q2 results. Technical indicators reinforce this caution: the stock is trading at ₹967 with a bearish Supertrend on both daily and monthly timeframes. Momentum is deteriorating, as shown by the 20-day EMA slope of -53.52 and a Plus DI (11.78) significantly lower than the Minus DI (33.59). The stock has suffered a severe drawdown, currently down 56.4% from its peak, with a maximum historical drawdown of 58.1%. Annualized volatility stands at +47.5%, indicating high risk. While Jefferies cites strong September quarter revenue growth (+38% YoY in insurance premiums), it also notes an adjusted EBITDA miss driven by higher advertising expenses and muted sequential momentum in credit disbursals due to cost management. This mix of margin pressure and slowing growth momentum underpins the cautious outlook.